FDA Grants “Emergency” Use Authorization to Yet Another “Updated” Coronavirus Vax

Here we go again.

Reuters:

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax’s COVID shot.

The updated vaccine is authorized for use in individuals 12 years of age and older and will target the JN.1 strain of the virus.

Shares of the company were up 2.2% in extended trading after closing 8.6% higher.

“Today’s authorization provides an additional COVID-19 vaccine option,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

Novavax’s traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA – Moderna’s Spikevax and Comirnaty, which is jointly developed by Pfizer and BioNTech.

Who is taking these vaccines at this point?

Apparently, it’s the people who still have “stand with the Ukraine” flags in their yards. Maybe those people are also still chanting “black lives matter.”